 SMC Global Securities Ltd Q2 FY2025-26 consolidated net profit declines to Rs. 20.65 crores
SMC Global Securities Ltd Q2 FY2025-26 consolidated net profit declines to Rs. 20.65 crores Rajoo Engineers Ltd Q2FY26 consolidated profit at Rs. 14.18 crores
Rajoo Engineers Ltd Q2FY26 consolidated profit at Rs. 14.18 crores Inventurus Knowledge Solutions Ltd consolidated Q2 FY2025-26 PAT climbs to Rs. 180.71 crores
Inventurus Knowledge Solutions Ltd consolidated Q2 FY2025-26 PAT climbs to Rs. 180.71 crores IFB Industries Ltd consolidated PAT for Q2FY26 jumps to Rs. 50.79 crores
IFB Industries Ltd consolidated PAT for Q2FY26 jumps to Rs. 50.79 crores Share India Securities Ltd consolidated Q2 FY26 net profit at Rs. 92.91 crores
Share India Securities Ltd consolidated Q2 FY26 net profit at Rs. 92.91 crores 
              The Committee of the Board (the 'Committee') of Aarey Drugs & Pharmaceuticals Ltd at its meeting held today has passed the following in connection with the Issue:
- Approved the issue price of Rs. 54.93/- per Equity share ( including premium of Rs. 44.93/- per Equity share) for issuance & allocation of 33,00,000 Equity shares to eligible Qualified Institutional Buyers in the Qualified Institutional Placement, aggregating to Rs. 1,812.69 Lakhs.
- Approved and adopted the Placement document dated March 20, 2018, in connection with the Issue, (the " Placement Document").
- Approved the issue of confirmation of allocation notes to Qualified Institutional Buyers.
Shares of AAREY DRUGS & PHARMACEUTICALS LTD. was last trading in BSE at Rs.52.45 as compared to the previous close of Rs. 52.55. The total number of shares traded during the day was 180151 in over 247 trades.
The stock hit an intraday high of Rs. 53.9 and intraday low of 51. The net turnover during the day was Rs. 9499545.